Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2026-02-21 @ 1:36 AM
Study NCT ID:
NCT03107793
Status:
COMPLETED
Last Update Posted:
2025-04-29
First Post:
2017-03-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab
Sponsor:
Janssen-Cilag Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-19
Start Date Type:
ACTUAL
Primary Completion Date:
2020-04-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-07-20
Completion Date Type:
ACTUAL
First Submit Date:
2017-03-28
First Submit QC Date:
None
Study First Post Date:
2017-04-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-04-28
Results First Submit QC Date:
None
Results First Post Date:
2021-05-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-25
Last Update Post Date:
2025-04-29
Last Update Post Date Type:
ACTUAL